11 Jan 2021 | 10:23 am | 1 min. read
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
The test, developed by German molecular diagnostics company GNA Biosolutions, has been approved by the domestic regulatory German Federal Institute for Drugs and Medical Devices (BfArM). The new PCR test, which produces a result in 40 minutes, is being rolled out across Germany with EU-wide approval expected in the coming months
The reliability of the rapid test system by GNA Biosolutions is comparable to common PCR tests, which, however, require up to 48 hours for a result.
The Pinsent Masons team advising on the deal was led by corporate partner Tobias Rodehau and included head of German public and regulatory Dr. Anke Empting, commercial and IP partner Dr. Michael Reich, technology, science and industry sector head Dr. Florian von Baum, head of German IP Marc Holtorf, and commercial legal director Dr. Igor Barabash.
Commenting on the project, Tobias Rodehau, said: "We are proud to have been able to assist GNA Biosolutions GmbH with this important project. Thanks to our expertise in the life sciences sector, we are familiar with the specifics of this industry and have been able to assemble a cross disciplinary team to play a role in facilitating swift access to this groundbreaking technology."
GNA Biosolutions GmbH is a long-standing client of Pinsent Masons. In 2019 the firm successfully advised the company on its USD 13.5 million Series C financing.
The Bavarian state government has acquired six GNA Biosolutions test devices, which were officially approved in December, as well as 60,000 test kits.
Tobias specialises in small and mid-cap private equity transactions, with a focus on venture capital transactions.
Rechtsanwältin, Partner, Head of Düsseldorf office
Anke specialises in Public Commercial Law/Public Sector and has more than 10 years' experience in advising the public sector.
Rechtsanwalt, Partner, Sector Head Technology, Science & Industry
Florian is the Global Head of Technology, Science & Industry
Rechtsanwalt, Partner, Head of German Life Sciences
Marc is Deputy Head of Pinsent Masons Germany. He also heads the German Life Sciences team. He specialises in supporting pharmaceutical, medical device and other high-tech companies in navigating through the complex world of contentious and non-contentious intellectual property.
Multinational law firm Pinsent Masons has been named as a top ten family friendly employer by the national charity for working parents and carers Working Families.
Multinational law firm Pinsent Masons MPillay is supporting the Asian Development Bank (ADB) on its role advising the Philippines Department of Transportation (DOTr) on the refurbishment and expansion of the Ninoy Aquino International Airport (NAIA) in Manila.
Multinational law firm Pinsent Masons has advised global renewable energy developer BayWa r.e. on its partnership with SUSI Partners to develop rooftop solar PV projects across Southeast Asia.
Multinational law firm Pinsent Masons has hired transactional life sciences specialist Michael Stewart as partner in its Dublin office as it expands its pan-European Technology, Science and Industry (TSI) capabilities.
Multinational law firm Pinsent Masons has hired Corporate Partner Camille Chiari who joined the firm’s Paris Office.
Multinational law firm Pinsent Masons has hired patent litigation partner James Marshall to join its London office.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on